Latest news with #KKR
Hans India
6 hours ago
- Sport
- Hans India
Andre Russell Retires from International Cricket After 15 Years with West Indies
West Indies all-rounder Andre Russell has decided to hang up his boots from international cricket. He will play his final two T20 matches against Australia at Sabina Park in Jamaica, which is also his home ground. Russell served his nation for 15 years. He is known for his hitting capabilities and match-winning performances. Russell played a total of 84 T20Is, scoring 1,078 runs and taking 61 wickets in his career. Notably, he was part of the West Indies teams that won the T20 World Cups twice in 2012 and 2016. In white ball cricket, he played 56 matches, scoring 1,034 runs and taking 70 wickets. He became a global T20 star, playing in over 500 league matches worldwide. Interestingly, the KKR player's retirement comes just months before the 2026 T20 World Cup. The West Indies Cricket Board took to X to thank him for his passion, power, and pride. His fans were surprised after they had come to know about his retirement. Thank You, DRE RUSS!🫶🏽 For 15 years, you played with heart, passion, and pride for the West Indies 🌴 From being a two-time T20 World Cup Champion to your dazzling power on and off the field.❤️ WI Salute You!🏏#OneLastDance #WIvAUS #FullAhEnergy — Windies Cricket (@windiescricket) July 16, 2025
Reuters
18 hours ago
- Business
- Reuters
KKR mulls acquisition of healthcare technology firm GPI, Bloomberg News reports
July 16 (Reuters) - KKR (KKR.N), opens new tab is considering a potential buyout of Italian health-care technology firm GPI SpA ( opens new tab, as the U.S. investment firm scouts for takeover targets amid the recent market volatility, Bloomberg News reported on Wednesday. KKR has been in talks with advisers in recent weeks as it considers a potential deal to take Trento-based GPI private, the report said, citing people with knowledge of the matter. The report added that the discussions might not lead to a transaction. KKR declined to comment, while GPI did not immediately respond when contacted by Reuters. An investment company backed by GPI Chief Executive Officer Fausto Manzana is the company's biggest shareholder, with a 48% stake, equivalent to 57.3% of the voting rights, according to GPI's website. Europe is "a very interesting place to invest," Henry Kravis, KKR's co-founder told Bloomberg in an interview in May. KKR has invested about $30 billion since the start of the year, about half of that offshore. British scientific instruments maker Spectris (SXS.L), opens new tab earlier this month agreed to a takeover offer from KKR, valuing it at 4.7 billion pounds ($6.31 billion). ($1 = 0.7452 pounds)
Bloomberg
20 hours ago
- Business
- Bloomberg
KKR Mulls Acquisition of Health-Care Technology Firm GPI
KKR & Co., the buyout firm that's been scouting for takeover targets amid the recent market volatility, is considering a potential acquisition of Italian health-care technology firm GPI SpA, according to people with knowledge of the matter. The US private equity firm has been speaking with advisers in recent weeks as it considers a potential deal to take Trent-based GPI private, the people said, asking not to be identified as the matter is private. Shares of GPI have risen 24% in Milan trading this year, giving the company a market value of about €377 million ($438 million).
Yahoo
21 hours ago
- Business
- Yahoo
New Reports Call UnitedHealth's Earnings Momentum Into Question. How Should You Play UNH Stock Here?
UnitedHealth (UNH) shares closed lower on Tuesday following reports it quietly sold stakes in its business units to private equity firms like KKR (KKR) and Warburg Pincus last year to record up to $3.3 billion in additional profits. The timing, with most transactions executed in Q4, and the structure of these deals, which include buyback clauses, suggest the insurance giant may have used them to preserve its 60-quarter streak of beating earnings estimates. More News from Barchart Dear Nvidia Stock Fans, Mark Your Calendars for July 16 How to Buy Tesla for a 13% Discount, or Achieve a 26% Annual Return Retirement Ready: 3 Dividend Stocks to Set and Forget Our exclusive Barchart Brief newsletter is your FREE midday guide to what's moving stocks, sectors, and investor sentiment - delivered right when you need the info most. Subscribe today! As of this writing, UnitedHealth stock is down more than 50% versus its year-to-date high. Why These Reports are Negative for UnitedHealth Stock Reports that UNH relied on discreetly selling stakes to meet earnings expectations raises serious questions about the sustainability of its profit growth. While the transactions aren't illegal, their timing and lack of explicit disclosure imply a strategic effort to mask rising medical costs and operational strain. Such maneuvers distort the company's true financial health, potentially undermining trust in its long-standing earnings consistency. More importantly, agreements that UnitedHealth signed with the PE firms bind it to eventually repurchase the divested stakes at a higher price – adding long-term liabilities that could weigh on future cash flow and earnings quality as well. All in all, if the aforementioned reports were to make investors view the healthcare giant's results as engineered rather than earned, UNH shares could come further under pressure in the coming weeks and months. Is it Worth Buying UNH Shares at Current Levels? While challenges continue to pile up for UnitedHealth shares, analysts at Wolfe Research believe the ongoing weakness in the healthcare stock may be an opportunity to initiate a position at a deep discount. On Tuesday, the investment firm reiterated its 'Outperform' rating on UNH stock, citing significant undervaluation. The company is currently going for a forward price-earnings (P/E) multiple of less than 14x, which is well below its historical average. However, acknowledging its ongoing struggles, Wolfe analysts lowered their price target on UNH to $330 in their research note – but that, nonetheless, indicates potential upside of 14% from here. Wall Street Agrees With Wolfe on UnitedHealth Group UnitedHealth stock is currently trading at an unprecedented discount, which is keeping other Wall Street firm meaningfully positive on it as well. According to Barchart, the consensus rating on UNH shares remains at 'Moderate Buy' and the mean target of about $360 indicates potential upside of nearly 24% from current levels. On the date of publication, Wajeeh Khan did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
a day ago
- Business
- Business Wire
KKR Releases 2025 Mid-Year Global Macro Outlook
NEW YORK--(BUSINESS WIRE)--KKR, a leading global investment firm, today released its 2025 Mid-Year Global Macro Outlook by Henry McVey, CIO of KKR's Balance Sheet and Head of Global Macro and Asset Allocation (GMAA). In 'Make Your Own Luck,' McVey and his team explain why, despite the turbulent start to 2025 and additional expected market drawdowns, they remain positive in their outlook. They note their strong belief that attractive financial conditions, a global easing cycle, ongoing productivity gains, and lack of net issuance—coupled with compelling, powerful investment themes—will drive this cycle both further and longer than many think. And, while they acknowledge that the low rate, low volatility beta trade that defined 2015-2021 is now over, they advocate that investors stay the course by leveraging the team's long-standing Regime Change framework and investing behind priority macro trends. Against this backdrop, the team suggests investors 'make their own luck' by tilting towards assets that rely on collateral-based cash flows, can adjust to rising input costs, and/or enhance operational improvement—like control positions with operational upside in Private Equity, senior slices of Credit amid wide dispersions, or Real Assets with long-dated, inflation-linked contracts that can reprice alongside rising nominal GDP. The report also examines what has remained constant and what has shifted in the team's thinking since their 2025 Outlook published last December. Consistent with prior thinking, the team believes we continue to see a stellar technical backdrop, capital markets responding favorably to a global easing cycle, and sustained positive earnings momentum despite tariff-induced uncertainty. McVey and his team also share updated asset allocation picks and pans, refreshed expected return forecasts, and new model portfolios they believe are well-positioned to outperform in the continued Regime Change environment. They make several out-of-consensus calls, which include their beliefs that: The technical picture remains much better than investors think—net issuance of IPOs, levered loans, and high yield remain at levels not seen since 2009. We are in a productivity cycle similar to the 1990s, which will drive markets longer and higher than consensus. Lower taxes, higher margins, and higher quality earnings all suggest U.S. markets are reasonably valued vs. overvalued. Europe will perform better for longer, amid a stronger euro, more defense and infrastructure spending, continued interest in renewables, deeper capital markets, and less onerous cross-border restrictions. The oil market will move into larger surpluses over the next six to 12 months, driving WTI oil prices back down to $60 per barrel on average in the second half of 2025 and 2026. The unemployment rate will stay lower for longer relative to prior cycles, even against a modest payroll backdrop with gains increasingly concentrated in just a few sectors. Private Equity will remain a top-performing asset class as it continues to benefit from dispersion and control, allowing investors to lean into operational improvement and accretive M&A activity. There is increased opportunity for private investment in Infrastructure due to government retrenchment amid fiscal constraints, energy transition needs, and geopolitical competition. In addition, the report details the GMAA team's updated views on global economic forecasts, inflation, interest rates, currencies, and capital markets. The report also addresses key investor queries on topics such as how Europe can improve its competitive positioning, the team's outlook for expected returns, and their latest thinking on relative value in Credit and the potential direction of individual retirement accounts (401(k), annuities, etc.). Links to access this report in full as well as an archive of Henry McVey's previous publications follow: To read the full report, click here. For an archive of previous publications please visit About Henry McVey Henry H. McVey joined KKR in 2011 and is Head of the Global Macro, Balance Sheet and Risk team. Mr. McVey also serves as Chief Investment Officer for the Firm's Balance Sheet, oversees Firmwide Market Risk at KKR, and co-heads KKR's Strategic Partnership Initiative. As part of these roles, he sits on the Firm's Global Operating Committee and the Risk & Operations Committee. Prior to joining KKR, Mr. McVey was a Managing Director, Lead Portfolio Manager and Head of Global Macro and Asset Allocation at Morgan Stanley Investment Management (MSIM). Learn more about Mr. McVey here. About KKR KKR is a leading global investment firm that offers alternative asset management as well as capital markets and insurance solutions. KKR aims to generate attractive investment returns by following a patient and disciplined investment approach, employing world-class people, and supporting growth in its portfolio companies and communities. KKR sponsors investment funds that invest in private equity, credit and real assets and has strategic partners that manage hedge funds. KKR's insurance subsidiaries offer retirement, life and reinsurance products under the management of Global Atlantic Financial Group. References to KKR's investments may include the activities of its sponsored funds and insurance subsidiaries. For additional information about KKR & Co. Inc. (NYSE: KKR), please visit KKR's website at For additional information about Global Atlantic Financial Group, please visit Global Atlantic Financial Group's website at The views expressed in the report and summarized herein are the personal views of Henry McVey of KKR and do not necessarily reflect the views of KKR or the strategies and products that KKR manages or offers. Nothing contained herein constitutes investment, legal, tax or other advice nor is it to be relied on in making an investment decision or any other decision. This release is prepared solely for information purposes and should not be viewed as a current, past or future recommendation or a solicitation of an offer to buy or sell any securities or to adopt any investment strategy. This release contains forward-looking statements, which are based on beliefs, assumptions and expectations that may change as a result of many possible events or factors. If a change occurs, actual results may vary materially from those expressed in the forward-looking statements. All forward-looking statements speak only as of the date such statements are made, and neither KKR nor Mr. McVey assumes any duty to update such statements except as required by law.
